Kendall Capital Management’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.72M	Sell	6,281 -278	-4%	-$138K	0.76%	31
2025 Q4	$3.2M	Sell	6,559 -591	-8%	-$275K	0.67%	37
2025 Q3	$3M	Sell	7,150 -30	-0.4%	-$10.1K	0.68%	39
2025 Q2	$2.06M	Sell	7,180 -90	-1%	-$26.9K	0.55%	52
2025 Q1	$2.24M	Buy	7,270 +475	+7%	+$163K	0.66%	45
2024 Q4	$2.4M	Buy	6,795 +253	+4%	+$93K	0.7%	44
2024 Q3	$2.34M	Buy	6,542 +340	+5%	+$115K	0.72%	41
2024 Q2	$1.98M	Buy	6,202 +550	+10%	+$146K	0.66%	45
2024 Q1	$1.3M	Buy	5,652 +1,440	+34%	+$325K	0.45%	70
2023 Q4	$926K	Buy	4,212 +1,310	+45%	+$302K	0.36%	91
2023 Q3	$655K	Buy	2,902 +1,557	+116%	+$359K	0.29%	106
2023 Q2	$297K	Buy	+1,345	New	+$298K	0.13%	160
2018 Q4	–	Sell	-1,690	Closed	-$216K	–	115
2018 Q3	$216K	Sell	1,690 -1,545	-48%	-$191K	0.18%	104
2018 Q2	$366K	Sell	3,235 -1,275	-28%	-$140K	0.32%	85
2018 Q1	$507K	Buy	4,510 +125	+3%	+$15.9K	0.44%	70
2017 Q4	$649K	Buy	+4,385	New	+$557K	0.58%	55